스미스앤드네퓨 SNATS (SNN) 주가

스미스앤드네퓨 SNATS(SNN)는 NYSE에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $27.56 (-0.79%), 시가총액 $13.11B, PER (주가수익비율) 21.51, 52주 최저~최고 $28.58 ~ $38.70.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and impla

핵심 지표

• 현재가: $27.56 (-0.79%)
• 시가총액: $13.11B
• PER (주가수익비율): 21.51
• 52주 최저~최고: $28.58 ~ $38.70
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NYSE

스미스앤드네퓨 SNATS의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

스미스앤드네퓨 SNATS 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.75

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.48
• 순이익률: 0.10%
• 영업이익률: 0.14%
• 배당수익률: 0.03%

자주 묻는 질문